These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 24198222

  • 1. Influence of starting material particle size on pellet surface roughness.
    Sarkar S, Ang BH, Liew CV.
    AAPS PharmSciTech; 2014 Feb; 15(1):131-9. PubMed ID: 24198222
    [Abstract] [Full Text] [Related]

  • 2. Insights into the functionality of pelletization aid in pelletization by extrusion-spheronization.
    Sarkar S, Heng PW, Liew CV.
    Pharm Dev Technol; 2013 Feb; 18(1):61-72. PubMed ID: 21981607
    [Abstract] [Full Text] [Related]

  • 3. Influence of MCC II fraction and storage conditions on pellet properties.
    Krueger C, Thommes M, Kleinebudde P.
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
    [Abstract] [Full Text] [Related]

  • 4. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
    Verheyen P, Steffens KJ, Kleinebudde P.
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1325-32. PubMed ID: 19832632
    [Abstract] [Full Text] [Related]

  • 5. Formulation and evaluation of mefenamic acid sustained release matrix pellets.
    Ibrahim MA.
    Acta Pharm; 2013 Mar; 63(1):85-98. PubMed ID: 23482315
    [Abstract] [Full Text] [Related]

  • 6. Functionality of cross-linked polyvinylpyrrolidone as a spheronization aid: a promising alternative to microcrystalline cellulose.
    Liew CV, Gu L, Soh JL, Heng PW.
    Pharm Res; 2005 Aug; 22(8):1387-98. PubMed ID: 16078149
    [Abstract] [Full Text] [Related]

  • 7. [Correlations between micromeritic properties of mixing powders of danshen extract and formability of their pellets].
    Xtong ZW, Luo Y, Liao ZG, Zhao GW, Li Z, Luo J.
    Zhongguo Zhong Yao Za Zhi; 2014 Nov; 39(22):4317-23. PubMed ID: 25850259
    [Abstract] [Full Text] [Related]

  • 8. Importance of wet packability of component particles in pellet formation.
    Sarkar S, Wong TW, Liew CV.
    AAPS PharmSciTech; 2013 Sep; 14(3):1267-77. PubMed ID: 23955149
    [Abstract] [Full Text] [Related]

  • 9. The influence of microcrystalline cellulose grade on shape and shape distributions of pellets produced by extrusion-spheronization.
    Koo OM, Heng PW.
    Chem Pharm Bull (Tokyo); 2001 Nov; 49(11):1383-7. PubMed ID: 11724226
    [Abstract] [Full Text] [Related]

  • 10. Properties of microcrystalline cellulose and powder cellulose after extrusion/spheronization as studied by fourier transform Raman spectroscopy and environmental scanning electron microscopy.
    Fechner PM, Wartewig S, Füting M, Heilmann A, Neubert RH, Kleinebudde P.
    AAPS PharmSci; 2003 Nov 19; 5(4):E31. PubMed ID: 15198519
    [Abstract] [Full Text] [Related]

  • 11. Influence of formulation and excipient variables on the pellet properties prepared by extrusion spheronization.
    Sinha VR, Agrawal MK, Kumria R.
    Curr Drug Deliv; 2005 Jan 19; 2(1):1-8. PubMed ID: 16305403
    [Abstract] [Full Text] [Related]

  • 12. Use of extrusion aids for successful production of Kollidon® CL-SF pellets by extrusion-spheronization.
    Loka NC, Saripella KK, Pinto CA, Neau SH.
    Drug Dev Ind Pharm; 2018 Apr 19; 44(4):632-642. PubMed ID: 29183166
    [Abstract] [Full Text] [Related]

  • 13. The evaluation of formulations for the preparation of pellets with high drug loading by extrusion/spheronization.
    Podczeck F, Knight P.
    Pharm Dev Technol; 2006 Apr 19; 11(3):263-74. PubMed ID: 16895837
    [Abstract] [Full Text] [Related]

  • 14. Effect of microcrystalline cellulose grade and process variables on pellets prepared by extrusion-spheronization.
    Alvarez L, Concheiro A, Gómez-Amoza JL, Souto C, Martínez-Pacheco R.
    Drug Dev Ind Pharm; 2002 Apr 19; 28(4):451-6. PubMed ID: 12056538
    [Abstract] [Full Text] [Related]

  • 15. Powdered cellulose as excipient for extrusion-spheronization pellets of a cohesive hydrophobic drug.
    Alvarez L, Concheiro A, Gómez-Amoza JL, Souto C, Martínez-Pacheco R.
    Eur J Pharm Biopharm; 2003 May 19; 55(3):291-5. PubMed ID: 12754003
    [Abstract] [Full Text] [Related]

  • 16. New insights into the pelletization mechanism by extrusion/spheronization.
    Koester M, Thommes M.
    AAPS PharmSciTech; 2010 Dec 19; 11(4):1549-51. PubMed ID: 21042960
    [Abstract] [Full Text] [Related]

  • 17. The preparation by extrusion/spheronization and the properties of pellets containing drugs, microcrystalline cellulose and glyceryl monostearate.
    Chatchawalsaisin J, Podczeck F, Newton JM.
    Eur J Pharm Sci; 2005 Jan 19; 24(1):35-48. PubMed ID: 15626576
    [Abstract] [Full Text] [Related]

  • 18. Formulation of ranitidine pellets by extrusion-spheronization with little or no microcrystalline cellulose.
    Basit AW, Newton JM, Lacey LF.
    Pharm Dev Technol; 1999 Jan 19; 4(4):499-505. PubMed ID: 10578503
    [Abstract] [Full Text] [Related]

  • 19. Production and characterization of pellets using Avicel CL611 as spheronization aid.
    Puah SY, Yap HN, Chaw CS.
    Drug Dev Ind Pharm; 2014 Mar 19; 40(3):418-24. PubMed ID: 23480532
    [Abstract] [Full Text] [Related]

  • 20. A protocol for the classification of wet mass in extrusion-spheronization.
    Gao Y, Hong Y, Xian J, Lin X, Shen L, Zhang X, Zhang N, Feng Y.
    Eur J Pharm Biopharm; 2013 Nov 19; 85(3 Pt B):996-1005. PubMed ID: 23563104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.